Recurring Billing TRT Clinic: Consent, Eligibility, and Underwriting

Recurring billing for a TRT or hormone clinic may be commercially eligible, but approval depends on the complete business model, customer journey, disclosures, data handling, fulfillment relationships, jurisdictions, and processor underwriting. Before applying, document the recurring terms, affirmative consent, cancellation process, health claims, privacy responsibilities, and services included in each charge.

Recurring billing TRT clinic: at a glance

Can a TRT clinic use monthly recurring card payments?

A TRT clinic may be eligible for monthly recurring billing, but the processor evaluates the actual services, customer journey, marketing, ownership, fulfillment, jurisdictions, and transaction profile. Payment approval does not establish that the underlying clinical, pharmacy, telehealth, or controlled-substance model complies with applicable requirements.

A monthly charge might cover a membership, consultations, administrative access, laboratory services, medication, shipping, or a combination. Describe each component accurately before underwriting and avoid making customers infer what the recurring amount includes.

What must recurring billing consent include?

Before billing information is submitted, the enrollment flow should state the amount charged today, recurring amount, frequency, start date, trial or promotional terms, inclusions, extra charges, cancellation method, deadlines, refund policy, and failed-payment handling.

The FTC’s 2024 amended framework for negative-option programs described material-term disclosures, express informed consent, and cancellation obligations. In March 2026, however, the FTC described that 2024 rule as vacated and opened an Advance Notice of Proposed Rulemaking. Do not present the vacated 2024 “Click-to-Cancel” provisions as currently enforceable without current legal review.

Use that framework as an operational benchmark while confirming current requirements. Separate payment authorization from clinical consent, electronic-communications consent, medication or laboratory authorization, and membership terms. Preserve the checkout version shown, timestamp, customer identity, checkbox or signature record, and available enrollment metadata. The 2024 FTC framework stated that consent evidence should be maintained for at least three years; verify the current enforceable requirement before relying on that period.

How should a hormone clinic structure its recurring charge?

A hormone clinic should identify exactly what each recurring charge covers and clearly distinguish included services from separately priced items.

1. 1Name the legal merchant and merchant of record.
2. 2List every component delivered after enrollment.
3. 3State inclusions, exclusions, extra charges, and timing.
4. 4Show today’s charge, recurring amount, frequency, and start date.
5. 5Display cancellation, pause, refund, and failed-payment terms.
6. 6Confirm an accurate, recognizable statement descriptor.
7. 7Match checkout language to the processor application and customer agreement.

Bundling can affect refunds, disputes, underwriting, and customer understanding. Whether services should be billed separately is a fact-specific legal and operational question, not a payment-processing safe harbor.

Does HIPAA apply to recurring-payment data?

HIPAA applies to covered entities and business associates under the conditions established by the HIPAA Privacy Rule; whether a particular payment or technology vendor is a business associate depends on the services performed and information handled.

Under 45 C.F.R. Part 164, Subpart E, certain uses and disclosures for payment and health-care operations are permitted subject to the rule’s limits. Review the roles of processors, billing platforms, patient portals, CRMs, analytics vendors, and payment-orchestration services individually. Do not place diagnoses, treatment details, laboratory results, medication information, or unnecessary clinical notes in payment fields, support tickets, descriptors, or marketing systems.

Map data from enrollment through payment, support, clinical care, laboratories, fulfillment, and marketing. Determine whether a business-associate agreement is needed, define access and retention, and document incident response and offboarding. The HIPAA Breach Notification Rule, 45 C.F.R. §§ 164.400–414, can require individual notice without unreasonable delay and no later than 60 days after discovery, subject to applicable exceptions and analysis.

A non-HIPAA health-data business may also face the FTC Health Breach Notification Rule, 16 C.F.R. Part 318. The FTC announced amendments on April 26, 2024, including clarification involving health apps and similar technologies.

What claims can a TRT clinic make?

Health-related advertising must be truthful, not misleading, and supported by competent and reliable scientific evidence under the FTC’s Health Products Compliance Guidance and the FTC Act, including Sections 5 and 12.

Review landing pages, membership descriptions, emails, testimonials, reviews, social posts, FAQs, and before-and-after materials—not only checkout copy. Avoid unsupported claims that hormone therapy will reliably produce weight loss, reverse aging, cure fatigue, restore fertility, prevent disease, improve athletic performance, or deliver a stated result for most patients.

Under the FTC’s Endorsement Guides, 16 C.F.R. Part 255, endorsements cannot convey claims the clinic could not make directly. Compensation, employment, discounts, free services, and other material connections should be disclosed clearly and conspicuously. Do not manufacture or buy fake reviews, manipulate ratings, or use testimonials in ways that imply unsupported typical results.

Do controlled-substance operations affect underwriting?

Controlled-substance operations may require separate legal and operational review; payment approval does not establish that prescribing, dispensing, recordkeeping, telehealth, pharmacy, or fulfillment practices comply with applicable requirements.

This payment guide does not address prescribing, dosing, sourcing, product access, administration, or patient use. Underwriting materials should accurately describe the clinical and fulfillment model without treating processor approval as proof of legality.

What do underwriters examine before approving recurring healthcare billing?

The processor or acquiring bank decides eligibility commercially based on the complete model and application. Review questions may include:

• Does the business sell clinical services, products, or both?
• Is medication or laboratory work included in the recurring charge?
• Who is the merchant of record?
• What are the card-not-present volume, refund history, and dispute history?
• How do fulfillment and continuity procedures work?
• Who owns the company, and what is its corporate structure?
• Which states or jurisdictions are served?
• Which vendors handle payment, PHI, clinical care, laboratories, or fulfillment?
• Does the live website match the proposed business model?

The approved research does not verify card-network thresholds, reserve percentages, recurring-billing fees, or processor-specific approval rules. Request written underwriting terms rather than relying on generic claims about high-risk healthcare accounts. See telehealth merchant account underwriting documents for related documentation considerations.

What state and jurisdictional review is needed?

Review every jurisdiction in scope for automatic-renewal laws, renewal notices, telehealth consent, professional licensing, corporate-practice restrictions, pharmacy and shipping rules, advertising, privacy, breach notification, consumer-health data, refunds, and tax treatment.

The approved federal research does not support a state-by-state conclusion. Requirements may affect the clinical entity, professional relationships, fulfillment model, subscription terms, compensation arrangements, and disclosures. Processor approval does not resolve those questions.

What changed recently?

• April 26, 2024: The FTC announced amendments to the Health Breach Notification Rule, including health-app coverage clarification and updated notice provisions.
• October 16, 2024: The FTC announced its final “Click-to-Cancel” rule for recurring subscriptions and negative-option programs.
• March 11, 2026: The FTC issued an Advance Notice of Proposed Rulemaking on negative-option marketing and described the 2024 rule as vacated. The notice is not a final replacement rule.
• Before publication or launch: Verify the current eCFR and Federal Register status of 16 C.F.R. Parts 425 and 318.

What should a clinic do before applying?

1. 1Define the model: Document the merchant of record, ownership, services, jurisdictions, fulfillment, and every recurring-charge component.
2. 2Map data flows: Include enrollment, payment, clinical care, laboratories, fulfillment, support, analytics, and marketing.
3. 3Build disclosures: Show amount, frequency, first charge, renewal, inclusions, exclusions, cancellation, refunds, and statement descriptor.
4. 4Obtain review: Assess automatic-renewal, telehealth, privacy, advertising, pharmacy, licensing, and controlled-substance requirements.
5. 5Document relationships: Identify who performs evaluation, care, laboratory, dispensing, shipping, support, and continuity functions.
6. 6Separate consents: Keep billing authorization distinct from clinical and communications consents.
7. 7Ask the processor in writing: Confirm eligibility, recurring transactions, descriptors, reserves, settlement, limits, documentation, and prohibited activity.
8. 8Submit consistently: Ensure the application matches the live website, agreements, vendors, customer journey, and projected transactions.

MDLaunchr is the brand behind WhiteLabelClinic.com, a white-label telehealth infrastructure platform designed to help qualified businesses evaluate and coordinate technology, operational, compliance, clinical-network, and fulfillment relationships. Explore how MDLaunchr and WhiteLabelClinic.com can support a compliance-first telehealth launch.

Related reading: the full guide this article belongs to.